We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEDG icon
826
SolarEdge
SEDG
$2.56B
$7.52M 0.01%
105,878
+99,608
+1,589% +$7.19M
ERIC icon
827
Ericsson
ERIC
$31.4B
$7.51M 0.01%
+1,362,086
New +$7.68M
EME icon
828
Emcor
EME
$32.4B
$7.5M 0.01%
+21,430
New +$5.75M
CCS icon
829
Century Communities
CCS
$2.03B
$7.5M 0.01%
77,742
+60,174
+343% +$5.28M
SU icon
830
Suncor Energy
SU
$75.8B
$7.49M 0.01%
+202,900
New +$6.83M
KALV
831
DELISTED
KalVista Pharmaceuticals
KALV
$7.46M 0.01%
+628,887
New +$8.38M
MSA icon
832
Mine Safety
MSA
$6.71B
$7.42M 0.01%
38,304
+25,105
+190% +$4.41M
TAL icon
833
TAL Education Group
TAL
$5.83B
$7.39M 0.01%
651,380
-426,257
-40% -$5.31M
FWRD icon
834
Forward Air
FWRD
$490M
$7.39M 0.01%
237,574
+103,266
+77% +$4.32M
PRAX icon
835
Praxis Precision Medicines
PRAX
$9B
$7.38M 0.01%
121,024
+72,182
+148% +$3.24M
BKNG icon
836
Booking.com
BKNG
$143B
$7.38M 0.01%
+50,875
New +$7.25M
DD icon
837
DuPont de Nemours
DD
$18.6B
$7.37M 0.01%
76,534
-293,984
-79% -$26.2M
EVER icon
838
EverQuote
EVER
$925M
$7.3M 0.01%
393,335
+25,325
+7% +$372K
NYT icon
839
New York Times
NYT
$11.9B
$7.29M 0.01%
168,687
-331,769
-66% -$15.1M
INTU icon
840
Intuit
INTU
$83.9B
$7.26M 0.01%
11,165
-118,159
-91% -$75.4M
TBLA icon
841
Taboola.com
TBLA
$1.35B
$7.21M 0.01%
1,624,605
+1,371,025
+541% +$6.11M
ALTR
842
DELISTED
Altair Engineering Inc
ALTR
$7.21M 0.01%
83,700
+75,773
+956% +$6.44M
TGT icon
843
Target
TGT
$63.3B
$7.21M 0.01%
40,690
-411,829
-91% -$62.7M
EWZ icon
844
CALL
iShares MSCI Brazil ETF
EWZ
$9.06B
$7.18M 0.01%
+224,600
New +$7.43M
IGSB icon
845
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
$7.18M 0.01%
140,000
HAE icon
846
Haemonetics
HAE
$3.65B
$6.95M 0.01%
81,395
+27,018
+50% +$2.12M
ALIT icon
847
Alight
ALIT
$536M
$6.93M 0.01%
35,183
+29,324
+500% +$5.31M
BHF icon
848
Brighthouse Financial
BHF
$3.64B
$6.92M 0.01%
+134,355
New +$6.67M
SILK
849
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$6.91M 0.01%
377,115
+11,713
+3% +$186K
TGLS icon
850
Tecnoglass
TGLS
$2B
$6.91M 0.01%
132,739
+74,339
+127% +$3.42M

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.